From October 1, 2022 to December 31, 2022, the company has repurchased 30,388,779 shares, representing 1.43% for $2,298.77 million. With this, the company has completed the repurchase of 388,815,367 shares, representing 19.76% for $24,831.24 million under the buyback announced on October 27, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.99 USD | +0.66% | -1.92% | -14.27% |
01/05 | HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50 | MT |
01/05 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.27% | 89.17B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on October 27, 2016.